Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

SHE:300436 Revenue

Fujian Cosunter Pharmaceutical had revenue of 111.25M CNY in the quarter ending June 30, 2025, with 13.37% growth. This brings the company's revenue in the last twelve months to 432.14M, down -6.75% year-over-year. In the year 2024, Fujian Cosunter Pharmaceutical had annual revenue of 441.46M with 4.43% growth.

• Revenue (ttm): 432.14M
• Revenue Growth: -6.75%
• P/S Ratio: 41.78
• Revenue / Employee: 568.60K
• Employees: 760
• Market Cap: 18.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	441.46M	18.74M	4.43%
Dec 31, 2023	422.71M	36.95M	9.58%
Dec 31, 2022	385.77M	15.32M	4.14%
Jan 1, 2022	370.44M	1.95M	0.53%
Dec 31, 2020	368.49M	-46.38M	-11.18%